Most affordable compounded semaglutide & tirzepatide in Illinois
⚠ Illinois legal details are prototype data — verify the Illinois Board of Pharmacy (IDFPR) link and current telehealth rules before publishing.
For Illinois residents, the lowest fully-credentialed flat price in our record is NexLife (semaglutide $145/mo, tirzepatide $186/mo), available in all 50 states. The lowest sticker price is Embody at $99/mo. Illinois generally expects a live (synchronous audio-video) visit to establish the provider–patient relationship before a first prescription. Pharmacies serving Illinois must hold Illinois Board of Pharmacy (IDFPR) licensure, and the state's monitoring program is the Illinois PMP.
01Illinois rules that affect your access
- RXTelehealth visit standardIllinois generally expects a live (synchronous audio-video) visit to establish the provider–patient relationship before a first prescription.
- PHPharmacy regulatorIllinois Board of Pharmacy (IDFPR) — idfpr.illinois.gov (verify link). Non-resident pharmacies shipping into Illinois must be licensed here.
- DBMonitoring programIllinois PMP.
- iState noteNon-resident pharmacy license required to ship into the state.
02Lowest-cost tirzepatide providers serving Illinois
| # | Provider | True/mo | 12-mo |
|---|---|---|---|
| ★ 1 | $186FLAT | $2,232 | |
| 2 | $99FLAT | $1,188 | |
| 3 | $149FLAT | $1,788 | |
| 4 | $179↑ | $2,148 | |
| 5 | $179FLAT | $2,148 |
03Lowest-cost semaglutide providers serving Illinois
| # | Provider | True/mo | 12-mo |
|---|---|---|---|
| ★ 1 | $145FLAT | $1,740 | |
| 2 | $280FLAT | $3,360 | |
| 3 | $99FLAT | $1,188 | |
| 4 | $149FLAT | $1,788 | |
| 5 | $169↑ | $2,028 |
04Lowest fully-credentialed option in Illinois
NexLife
★★★★★ Compounded semaglutide + tirzepatide- MD/DO-supervised care
- 503A & 503B pharmacy network
- Labs included
- LegitScript-certified
- NABP-accredited pharmacy partners
- Flat rate, dose-independent
- Third-party batch testing
- Care360 coaching included
Affiliate link. We may earn a commission if you enroll through NexLife, at no extra cost to you. It does not affect this ranking — see how we score providers.
05Is compounded GLP-1 legal in Illinois in 2026?
Illinois follows the same federal framework as the rest of the country: after the FDA resolved the semaglutide and tirzepatide shortages in 2025, broad compounding ended. Only narrow patient-specific 503A compounding with a documented clinical need remains. Read the full 2026 legal status explainer and our provider verification checklist before enrolling with any provider serving Illinois.
Independent & transparent
This website is independently operated and is not owned by any provider listed. Some outbound links may be affiliate or sponsored links. Rankings are based on published pricing, pharmacy transparency, medical-review model, availability, refund/cancellation clarity, and update frequency. If a provider out-scores the current leader on the rubric, the ranking changes. See our methodology → · Who pays us →